Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2018, Vol. 12 Issue (1) : 113-115
Pneumonic plague epidemic in Northeast China in 1910–1911: Dr. Wu Lien-Teh’s epidemic preventive system for plague control
Qingmeng Zhang, Fengmin Zhang(), Baofeng Yang()
Wu Lien-Teh Institute, Harbin Medical University, Harbin 150081, China
 Download: PDF(140 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Pneumonic plague that originated in Russian Siberia broke out in Northeast China in October 1910–March 1911. On the basis of field visits, autopsy, bacteriological identification, and close collaboration with local authorities and international colleagues, Dr. Wu Lien-Teh implemented a series of efficient antiplague measures, which successfully controlled the development of an extraordinary epidemic plague. In his subsequent work, Dr. Wu demonstrated the respiratory transmission of pneumonic plague and tarbagans’ role in this spread. Dr. Wu’s academic and cultural contributions are valuable in the medical progress in China.

Keywords pneumonic plague      prevention      epidemic control      Wu Lien-Teh     
Corresponding Authors: Fengmin Zhang,Baofeng Yang   
Just Accepted Date: 25 December 2017   Online First Date: 25 January 2018    Issue Date: 06 February 2018
 Cite this article:   
Qingmeng Zhang,Fengmin Zhang,Baofeng Yang. Pneumonic plague epidemic in Northeast China in 1910–1911: Dr. Wu Lien-Teh’s epidemic preventive system for plague control[J]. Front. Med., 2018, 12(1): 113-115.
Fig.1  Academic and cultural contributions of Dr. Wu Lien-Teh in Harbin. (A) Harbin Medical University as a new campus in 1954. (B) Wu Lien-Teh Memorial in the original location and buildings of North Manchurian Plague Prevention Service and its affiliated Pingchiang Hospital in Harbin.
1 [No authors listed.] Report of the International Plague Conference. Manila Bureau of Publishing, 1912
2 Wu  LT. Plague fighter: the authobiography of a modern Chinese physician. Cambridge: W. Heffer & Sons Ltd., 1959
3 Wu  LT, Chun  WH, Pollitzer R. Plague in Manchuria: I. Observations made during and after the Second Manchurian Plague Epidemic of 1920–21. II. The Role of the tarabagan in the epidemiology of plague. J Hyg (Lond)  1923; 21(3): 307–358 
pmid: 20474782
4 Wu LT. North Manchurian Plague Prevention Service Report (1911–1913). Cambridge: Cambridge University Press, 1914
5 Wu LT, Woodhead  GS. Note on the histology of some of the lesions found in pneumonic plague. J Pathol Bacteriol 1915; 19(1): 1–32
6 Chinese Plague Commission. Views of Harbin Fuchiatien taken during the plague epidemic, December 1910–March 1911. Shanghai: Commercial Press, Ltd., 1911
7 Wu  LT, Tuck  GL. Investigations into the relationship of the tarabagan (Mongolian marmot) to plague. Lancet 1913; 182(4695): 529–535
8 Wu LT, Eberson  F. Transmission of pulmonary and septicaemic plague among marmots. National Med J China 1916; 2(3): 6–13 
9 Wu LT. A treatise of pneumonic plague. League of Nations, Health Organization. 1926
10 Wu  LT, Chun  JWH, Pollitzer R,  Wu CY. A Manual for Medical and Public Health Workers. National Quarantine Service, China. 1936
[1] Yang Sun,Chenze Li,Lina Zhang,Dong Hu,Xudong Zhang,Ting Yu,Min Tao,Dao Wen Wang,Xiaoqing Shen. Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients[J]. Front. Med., 2017, 11(1): 53-61.
[2] Chunsong Hu,Qinghua Wu. Health: a dream from reality to the future[J]. Front. Med., 2016, 10(2): 233-235.
[3] Yi Cao. Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications[J]. Front. Med., 2015, 9(3): 261-274.
[4] James S. Park,Calvin Pan. Current recommendations of managing HBV infection in preconception or pregnancy[J]. Front. Med., 2014, 8(2): 158-165.
[5] Rui Yu,Rong Fan,Jinlin Hou. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China[J]. Front. Med., 2014, 8(2): 135-144.
[6] Jin Gao, Ben Panizza, Newell W. Johnson, Scott Coman, Alan R. Clough. Basic consideration of research strategies for head and neck cancer[J]. Front Med, 2012, 6(4): 339-353.
[7] Marie-Germaine Bousser. Stroke prevention: an update[J]. Front Med, 2012, 6(1): 22-34.
[8] Yiling Wu. Construction of the vessel-collateral theory and its guidance for prevention and treatment of vasculopathy[J]. Front Med, 2011, 5(2): 118-122.
[9] Shi-Ming CHENG MD, Yu-Ji LAI MS, Er-Yong LIU MS, Lin ZHOU MD, Xue-Jing WANG MS, Qiu-Lan CHEN MS, Dong-Ming LI MS, Ning WANG MD, . Study on factors affecting TB/HIV co-infection in four counties of China[J]. Front. Med., 2010, 4(2): 185-191.
[10] Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD, . Prevalence of cardiovascular diseases in China[J]. Front. Med., 2010, 4(1): 16-20.
[11] Qi MEI MM, Zhe CAO MM, Hua XIONG MD, Yuan CHEN MD, . Preliminary results of gentamycin combined with sodium bicarbonate for prevention of irinotecan-induced diarrhea[J]. Front. Med., 2009, 3(4): 470-474.
Full text